218Users Online
North America Vet Compounding Pharmacies Market Segmented By CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti- Inflammatory Agents Product in Oral, Injectables Formulation
1. Executive Summary
1.1. North America Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Rate/Usage Analysis – Key Statistics
4.2. Value Chain Analysis
4.3. Regulatory Scenario
4.4. Product USP Analysis
4.5. PESTEL Analysis
4.6. Porter’s Analysis
4.7. Key Promotional Strategies, By Key Players
5. Market Background
5.1. Macro-Economic Factors
5.1.1. North America GDP Growth Outlook
5.1.2. North America Healthcare Outlook
5.1.3. Global Compounding Pharmacies Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Product Adoption Rate
5.2.2. Prevalence of Chronic Diseases
5.2.3. Strategic Collaborations
5.2.4. Rising Pet Adoption
5.2.5. Cost of Product
5.2.6. Treatment Regime
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Animal Type
6.1.3. By Formulations
6.1.4. By Country
6.2. 2022 Market Scenario
7.North America Vet Compounding Pharmacies MarketDemand (in Value US$ Mn) Analysis 2014-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022
7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-inflammatory Agents
8.3.5. Others
8.4. Market Attractiveness Analysis, by Product
9. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Animal Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, by Animal Type, 2014-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Animal Type, 2023-2033
9.3.1. Companion Animals
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Equine
9.3.1.4. Others
9.3.2. Livestock Animals
9.4.市场吸引力分析,通过动物Type
10. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Formulations
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Formulations, 2014-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Formulations, 2023-2033
10.3.1. Oral
10.3.2. Injectable
10.3.3. Others
10.4. Market Attractiveness Analysis, by Formulations
11. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Country
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis, by Country, 2014-2022
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Country 2023-2033
11.3.1. U.S.
11.3.2. Canada
11.4. Market Attractiveness Analysis, by Country
12. U.S. Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
12.3.1. By Product
12.3.2. By Animal Type
12.3.3. By Formulations
12.4. Market Attractiveness Analysis
12.4.1. By Product
12.4.2. By Animal Type
12.4.3. By Formulations
13.加拿大兽医复合Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
13.3.1. By Product
13.3.2. By Animal Type
13.3.3. By Formulations
13.4. Market Attractiveness Analysis
13.4.1. By Product
13.4.2. By Animal Type
13.4.3. By Formulations
14. Market Structure Analysis
14.1. Market Analysis, by Tier of Companies
14.2. Market Share Analysis of Top Players
14.3. Market Concentration
14.4. Market Presence Analysis
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Deep Dive
15.2.1.Hoye’s Pharmacy
15.2.1.1. Overview
15.2.1.2. Product Portfolio
15.2.1.3. Sales Footprint
15.2.1.4. Key Financials
15.2.1.5.SWOT分析
15.2.1.6. Strategy Overview
15.2.1.6.1. Marketing Strategy
15.2.1.6.2. Product Strategy
15.2.1.6.3. Channel Strategy
15.2.2.Vertisis Custom Pharmacy
15.2.2.1. Overview
15.2.2.2. Product Portfolio
15.2.2.3. Sales Footprint
15.2.2.4. Key Financials
15.2.2.5. SWOT Analysis
15.2.2.6. Strategy Overview
15.2.2.6.1. Marketing Strategy
15.2.2.6.2. Product Strategy
15.2.2.6.3. Channel Strategy
15.2.3.Smith Caldwell Drug Store
15.2.3.1. Overview
15.2.3.2. Product Portfolio
15.2.3.3. Sales Footprint
15.2.3.4. Key Financials
15.2.3.5. SWOT Analysis
15.2.3.6. Strategy Overview
15.2.3.6.1. Marketing Strategy
15.2.3.6.2. Product Strategy
15.2.3.6.3. Channel Strategy
15.2.4.Sixth Avenue Medical Pharmacy
15.2.4.1. Overview
15.2.4.2. Product Portfolio
15.2.4.3. Sales Footprint
15.2.4.4. Key Financials
15.2.4.5. SWOT Analysis
15.2.4.6. Strategy Overview
15.2.4.6.1. Marketing Strategy
15.2.4.6.2. Product Strategy
15.2.4.6.3. Channel Strategy
15.2.5.Dougherty Pharmacy
15.2.5.1. Overview
15.2.5.2. Product Portfolio
15.2.5.3. Sales Footprint
15.2.5.4. Key Financials
15.2.5.5. SWOT Analysis
15.2.5.6. Strategy Overview
15.2.5.6.1. Marketing Strategy
15.2.5.6.2. Product Strategy
15.2.5.6.3. Channel Strategy
15.2.6.Triangle Compounding Pharmacy Inc.,
15.2.6.1. Overview
15.2.6.2. Product Portfolio
15.2.6.3. Sales Footprint
15.2.6.4. Key Financials
15.2.6.5. SWOT Analysis
15.2.6.6. Strategy Overview
15.2.6.6.1. Marketing Strategy
15.2.6.6.2. Product Strategy
15.2.6.6.3. Channel Strategy
15.2.7.Wedgewood Pharmacy
15.2.7.1. Overview
15.2.7.2. Product Portfolio
15.2.7.3. Sales Footprint
15.2.7.4. Key Financials
15.2.7.5. SWOT Analysis
15.2.7.6. Strategy Overview
15.2.7.6.1. Marketing Strategy
15.2.7.6.2. Product Strategy
15.2.7.6.3. Channel Strategy
15.2.8.Millers Pharmacy
15.2.8.1. Overview
15.2.8.2. Product Portfolio
15.2.8.3. Sales Footprint
15.2.8.4. Key Financials
15.2.8.5. SWOT Analysis
15.2.8.6. Strategy Overview
15.2.8.6.1. Marketing Strategy
15.2.8.6.2. Product Strategy
15.2.8.6.3. Channel Strategy
15.2.9.Chiron Compounding Pharmacy
15.2.9.1. Overview
15.2.9.2. Product Portfolio
15.2.9.3. Sales Footprint
15.2.9.4. Key Financials
15.2.9.5. SWOT Analysis
15.2.9.6. Strategy Overview
15.2.9.6.1. Marketing Strategy
15.2.9.6.2. Product Strategy
15.2.9.6.3. Channel Strategy
15.2.10.MEDS Canadian Compounding Pharmacy
15.2.10.1. Overview
15.2.10.2. Product Portfolio
15.2.10.3. Sales Footprint
15.2.10.4. Key Financials
15.2.10.5. SWOT Analysis
15.2.10.6. Strategy Overview
15.2.10.6.1. Marketing Strategy
15.2.10.6.2. Product Strategy
15.2.10.6.3. Channel Strategy
15.2.11.Aurora Compounding
15.2.11.1. Overview
15.2.11.2. Product Portfolio
15.2.11.3. Sales Footprint
15.2.11.4.关键财务
15.2.11.5. SWOT Analysis
15.2.11.6. Strategy Overview
15.2.11.6.1. Marketing Strategy
15.2.11.6.2. Product Strategy
15.2.11.6.3. Channel Strategy
15.2.12.Pace Pharmacy
15.2.12.1. Overview
15.2.12.2. Product Portfolio
15.2.12.3. Sales Footprint
15.2.12.4. Key Financials
15.2.12.5. SWOT Analysis
15.2.12.6. Strategy Overview
15.2.12.6.1. Marketing Strategy
15.2.12.6.2. Product Strategy
15.2.12.6.3. Channel Strategy
15.2.13.Victoria Compounding Pharmacy
15.2.13.1. Overview
15.2.13.2. Product Portfolio
15.2.13.3. Sales Footprint
15.2.13.4. Key Financials
15.2.13.5. SWOT Analysis
15.2.13.6. Strategy Overview
15.2.13.6.1. Marketing Strategy
15.2.13.6.2. Product Strategy
15.2.13.6.3. Channel Strategy
15.2.14.Pratt’s Compounding Pharmacy
15.2.14.1. Overview
15.2.14.2. Product Portfolio
15.2.14.3. Sales Footprint
15.2.14.4. Key Financials
15.2.14.5. SWOT Analysis
15.2.14.6. Strategy Overview
15.2.14.6.1. Marketing Strategy
15.2.14.6.2. Product Strategy
15.2.14.6.3. Channel Strategy
15.2.15.People’s Choice Pharmacy
15.2.15.1. Overview
15.2.15.2. Product Portfolio
15.2.15.3. Sales Footprint
15.2.15.4. Key Financials
15.2.15.5. SWOT Analysis
15.2.15.6. Strategy Overview
15.2.15.6.1. Marketing Strategy
15.2.15.6.2. Product Strategy
15.2.15.6.3. Channel Strategy
16. Assumptions and Acronyms Used
17. Research Methodology
FREEReport Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Product
Table 02: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Animal Type
Table 03: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Formulations
Table 05: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2014-2023 and Forecast 2023-2033, by Country
Table 06: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Product
Table 07: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Animal Type
Table 08: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Formulations
Table 09: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Product
Table 10: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Anima Type
Table 11: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Formulations
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionFigure 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014-2022
Figure 02: North America Vet Compounding Pharmacies Market Forecast & Y-o-Y Growth, 2023-2033
Figure 03: North America Vet Compounding Pharmacies Market Absolute $ Opportunity (US$ Mn) Analysis, 2023-2033
Figure 04: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 05: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Product
Figure 06: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Product
Figure 07: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Animal Type
Figure 08: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Animal Type
Figure 09: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Animal Type
Figure 10: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Formulations
Figure 11: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Formulations
Figure 12: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Formulations
Figure 13: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Country
Figure 14: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Country
Figure 15: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Country
Figure 16: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014–2022
Figure 17: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Forecast, 2023-2033
Figure 18: U.S. Vet Compounding Pharmacies Market Value Share, By Product (2023 E)
Figure 19: U.S. Vet Compounding Pharmacies Market Value Share, By Animal Type (2023 E)
Figure 20: U.S. Vet Compounding Pharmacies Market Value Share, By Formulations (2023 E)
Figure 21: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Product, 2023–2033
Figure 22: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Animal Type, 2023–2033
Figure 23: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Formulations, 2023–2033
Figure 24: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014–2022
Figure 25: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Forecast, 2023-2033
Figure 26: Canada Vet Compounding Pharmacies Market Value Share, By Product (2023 E)
Figure 27: Canada Vet Compounding Pharmacies Market Value Share, By Animal Type (2023 E)
Figure 28: Canada Vet Compounding Pharmacies Market Value Share, By Formulations (2023 E)
Figure 29: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Product, 2023–2033
Figure 30: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Animal Type, 2023–2033
Figure 31: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Formulations, 2023–2033
